Comparison between Laxmi Dental IPO and Senores Pharmaceuticals IPO.
Laxmi Dental IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Senores Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Laxmi Dental IPO is up to ₹698.06 Cr whereas the issue size of the Senores Pharmaceuticals IPO is up to ₹582.11 Cr. The final issue price of Laxmi Dental IPO is ₹428.00 per share and of Senores Pharmaceuticals IPO is ₹391.00 per share.
| Laxmi Dental IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹407.00 per share | ₹372.00 per share |
| Issue Price (Upper) | ₹428.00 per share | ₹391.00 per share |
| Issue Price (Final) | ₹428.00 per share | ₹391.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 33 shares | 38 shares |
| Fresh Issue Size | 32,24,299 shares | 1,27,87,723 shares |
| Fresh Issue Size (Amount) | up to ₹138.00 Cr | up to ₹500.00 Cr |
| OFS Issue Size | 1,30,85,467 shares | 21,00,000 shares |
| OFS Issue Size (Amount) | up to ₹560.06 Cr | up to ₹82.11 Cr |
| Issue Size Total | 1,63,09,766 shares | 1,48,87,723 shares |
| Issue Size Total (Amount) | up to ₹698.06 Cr | up to ₹582.11 Cr |
Laxmi Dental IPO opens on Jan 13, 2025, while Senores Pharmaceuticals IPO opens on Dec 20, 2024. The closing date of Laxmi Dental IPO and Senores Pharmaceuticals IPO is Jan 15, 2025, and Dec 24, 2024, respectively.
| Laxmi Dental IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Jan 10, 2025 | Dec 19, 2024 |
| Issue Open | Jan 13, 2025 | Dec 20, 2024 |
| Issue Close | Jan 15, 2025 | Dec 24, 2024 |
| Basis Of Allotment (Tentative) | Jan 16, 2025 | Dec 26, 2024 |
| Initiation of Refunds (Tentative) | Jan 17, 2025 | Dec 27, 2024 |
| Credit of Share (Tentative) | Jan 17, 2025 | Dec 27, 2024 |
| Listing date (Tentative) | Jan 20, 2025 | Dec 30, 2024 |
| Anchor Lockin End date 1 | Feb 14, 2025 | Jan 24, 2025 |
| Anchor Lockin End date 2 | Apr 15, 2025 | Mar 25, 2025 |
Laxmi Dental IPO P/E ratio is 87.77, as compared to Senores Pharmaceuticals IPO P/E ratio of 39.77.
| Laxmi Dental IPO | Senores Pharmaceuticals IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 46.56 | 66.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 41.7 | 45.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 87.77 | 39.77 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2352.38 Cr. | ₹1350.70 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 78.78% | 23.60% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 19.97% | 11.73% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.94 | 1.07 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.88 | ₹9.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 78.78% | 23.60% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Laxmi Dental IPO Retail Individual Investors (RII) are offered 16,30,976 shares while in Senores Pharmaceuticals IPO retail investors are offered 16,30,976 shares. Qualified Institutional Buyers (QIB) are offered 48,92,931 shares in Laxmi Dental IPO and 44,43,818 shares in Senores Pharmaceuticals IPO.
| Laxmi Dental IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 73,39,395 shares | 66,65,725 shares |
| Market Maker Reservation | 0 shares | |
| QIB | 48,92,931 shares | 44,43,818 shares |
| NII | 24,46,464 shares | 22,21,908 shares |
| RII | 16,30,976 shares | 14,81,272 shares |
| Employee | 0 shares | 75,000 shares |
| Others | ||
| Total | 1,63,09,766 shares | 1,48,87,723 shares |
Laxmi Dental IPO subscribed 114.14x in total, whereas Senores Pharmaceuticals IPO subscribed 97.86x.
| Laxmi Dental IPO | Senores Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 110.38x | 97.84x |
| NII (times) | 147.69x | 100.35x |
| Big NII (times) | 167.68x | 95.25x |
| Small NII (times) | 107.70x | 111.35x |
| RII (times) | 75.10x | 93.16x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 114.14x | 97.86x |
